Background Current standard radiotherapy for oropharynx cancer (OPC) is associated with
high rates of severe toxicities, shown to adversely impact patients' quality of life. Given …

Purpose We aim to determine the feasibility and dosimetric benefits of a novel MRI-guided
IMRT dose-adaption strategy for human papillomavirus positive (HPV+) oropharyngeal …

Abstract Objectives/Hypothesis: To evaluate the responsiveness of human papillomavirus
(HPV)‐positive and HPV‐negative oropharyngeal cancer to intensity‐modulated …

Purpose To perform a spatial analysis of local–regional recurrences, in relation to
quantitative dose distribution, among patients treated by intensity-modulated radiotherapy …

Purpose To report functional outcomes for patients with human papillomavirus–positive
oropharyngeal cancer treated on a phase 2 protocol of risk-and induction chemotherapy …

Purpose: We conducted a randomized phase II multicenter clinical trial to test the hypothesis
that physiologic MRI-based radiotherapy (RT) dose escalation would improve the outcome …

Simple Summary Adaptive radiotherapy for head and neck cancer has become more routine
due to an increase in imaging quality and improvement in radiation techniques. With the …

Human papillomavirus (HPV) is now the most common cause of oropharyngeal squamous
cell carcinoma (OPSCC) in the United States, with recent data suggesting that for every two …

Introduction Radiation dose-escalation for head and neck cancer (HNC) patients aiming to
improve cure rates is challenging due to the increased risk of unacceptable treatment …

Background Patients with HPV+ oropharyngeal squamous cell carcinoma were assigned to
dose and volume de-escalated radiotherapy (RT) or chemoradiotherapy (CRT) based on …